Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Tobii Technology in funding round led by Intel Capital
Mandate

Vinge advises Tobii Technology in funding round led by Intel Capital

March 23, 2012

Vinge has advised Tobii Technology AB on a USD 21 million investment by Intel Capital. Tobii Technology is the global leader in eye tracking and gaze interaction. Founded in 2001, Tobii continues to achieve rapid annual growth and receive awards and recognition for its accomplishments. Based in Sweden, Tobii has a global presence, with offices in the U.S., China, Germany, Japan and Norway. The funding by Intel will be used to continue R&D investments in core technology and to take eye tracking and gaze interaction to mainstream computers and other mass-market applications.

Vinge's team consisted of partner Johan Winnerblad together with associates Matthias Pannier and Karl Hahtovirta.

Related

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
August 13, 2025

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

 Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025